Corning, BioCision Announce Agreement
News Nov 13, 2015
Corning Incorporated and BioCision, LLC have announced an agreement that will enable laboratories around the world to further standardize and simplify key steps in their cell culture workflow.
On January 1, 2016, Corning will become the global distributor of popular BioCision products, including the innovative CoolCell® cell cryopreservation systems, CoolBox™ ice-free sample preparation systems, CoolRack® systems, and other associated products.
BioCision’s technologies are designed to standardize temperature-sensitive areas of the cell culture workflow, making sample handling more consistent and experimental outcomes more reproducible. This agreement will expand the reach and availability of these products by utilizing Corning’s global sales team and worldwide distribution network.
“Corning prides itself on continuously looking for ways to improve and streamline the workflow for our cell culture customers,” said Keith R. Olson, Ph.D., Corning Cell Culture business director. “BioCision’s solutions improve sample handling, as well as provide eco-friendly alternatives to current methods. The addition of BioCision products is a perfect complement to our expanding cell culture portfolio of vessels, surfaces and media.”
“Corning is a preeminent life science research company that shares our commitment to deliver high quality research tools to our mutual customers,” said Rolf O. Ehrhardt, M.D., Ph.D., BioCision chief executive officer. “This agreement provides unparalleled access to our workflow standardization solutions and also allows BioCision to focus further on innovation in sample and drug product handling.”
The products covered in the Corning and BioCision agreement include:
• CoolCell® alcohol-free cell freezing containers
• CoolBox™ ice-free bench top cooling systems
• CoolRack®, CoolSink®, and ThermalTray™ thermo-conductive sample tube and plate modules
• TruCool® ice pans and buckets
• CryoCeps™ cryogenic vial grippers
Corning Life Sciences continues to bring new and innovative laboratory technologies to researchers worldwide and help customers succeed by providing novel, high-quality products and services in cell culture, bioprocessing, drug discovery and development, genomics, and microbiology.
Insulin Goes Viral: Diabetes and Cancer-causing Mechanisms ExploredNews
Every cell in your body responds to the hormone insulin, and if that process starts to fail, you get diabetes. In an unexpected finding, scientists have identified four viruses that can produce insulin-like hormones that are active on human cells. The discovery brings new possibilities for revealing biological mechanisms that may cause diabetes or cancer.READ MORE
Stem-Cell Exosome Treatment Repairs Brain Damage Following StrokeNews
A team of researchers have developed a new treatment for stroke that reduces brain damage and accelerates the brain’s natural healing tendencies in animal models.READ MORE
Comments | 0 ADD COMMENT
World Advanced Therapies & Regenerative Medicine Congress
May 16 - May 18, 2018
3rd Annual Bioprocessing of Advanced Cellular Therapies
May 29 - May 30, 2018
Next Gen Regenerative Medicine & Tissue Engineering
May 29 - May 30, 2018